12.07.2015 Views

Nursing Care of Dyspnea: The 6th Vital Sign in Individuals with ...

Nursing Care of Dyspnea: The 6th Vital Sign in Individuals with ...

Nursing Care of Dyspnea: The 6th Vital Sign in Individuals with ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Nurs<strong>in</strong>g</strong> <strong>Care</strong> <strong>of</strong> <strong>Dyspnea</strong>: <strong>The</strong> <strong>6th</strong> <strong>Vital</strong> <strong>Sign</strong> <strong>in</strong> <strong>Individuals</strong> <strong>with</strong> Chronic Obstructive Pulmonary Disease (COPD)Prevalence and Impact <strong>of</strong> COPDS<strong>in</strong>ce the 1960s there has been an <strong>in</strong>crease <strong>in</strong> morbidity <strong>in</strong> women <strong>with</strong> COPD. <strong>The</strong>re has been an <strong>in</strong>crease<strong>in</strong> mortality especially <strong>in</strong> men (Lacasse, Brooks & Goldste<strong>in</strong>, 1999). In 1999 <strong>in</strong> Canada, COPD was the fourthlead<strong>in</strong>g cause <strong>of</strong> death <strong>in</strong> men (5,544 deaths) and the fifth <strong>in</strong> women (3,974 deaths) (Canadian Institute for HealthInformation, Canadian Lung Association, Health Canada & Statistics Canada, 2001). From 1988 to 1999, although therates among men decreased by 7%, mortality rates <strong>in</strong> women <strong>in</strong>creased by 53% and are still <strong>in</strong>creas<strong>in</strong>g.Mortality rates also <strong>in</strong>crease rapidly for all <strong>in</strong>dividuals over 75 years <strong>of</strong> age. <strong>The</strong> change <strong>in</strong> age structure <strong>of</strong>the population <strong>with</strong> an <strong>in</strong>creas<strong>in</strong>g number <strong>of</strong> people aged over 65 years will result <strong>in</strong> cont<strong>in</strong>ued <strong>in</strong>creases<strong>in</strong> mortality rates for COPD (particularly <strong>in</strong> women) <strong>in</strong> the foreseeable future. Furthermore, the estimatedmortality rate is a significant underestimation (Ernst, Bourbeau, Ra<strong>in</strong>ville, Benayoun & Suissa, 2000). In Canada <strong>in</strong>2000/2001, COPD was the seventh most common cause <strong>of</strong> hospitalization for men and the eighth mostcommon cause <strong>of</strong> hospitalization for women. Hospitalizations were greater for patients over 65 years <strong>of</strong>age. Risk <strong>of</strong> rehospitalization is approximately 40% among patients <strong>with</strong> COPD (Canadian Institute for HealthInformation, Canadian Lung Association, Health Canada & Statistics Canada, 2001).<strong>The</strong> economic burden for COPD <strong>in</strong> Canada is enormous. In 1998, $467 million was spent on hospital careand drugs for COPD. Direct costs (premature mortality, long and short term disability) were estimated at$1.2 billion, <strong>with</strong> total cost therefore, estimated at $1.67 billion. It is suggested that this figure significantlyunderestimates the true costs because it does not <strong>in</strong>clude physician costs or costs related to communitybasedhealth services (Canadian Institute for Health Information, Canadian Lung Association, Health Canada & StatisticsCanada, 2001).Key Po<strong>in</strong>ts■■■Mortality rates are <strong>in</strong>creas<strong>in</strong>g for all <strong>in</strong>dividuals over 75 years <strong>of</strong> age.In 1999 <strong>in</strong> Canada, COPD was the fourth lead<strong>in</strong>g cause <strong>of</strong> death <strong>in</strong> menand the fifth <strong>in</strong> women.Healthcare costs for COPD <strong>in</strong> Canada represent an enormouseconomic burden.20

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!